Cost-effectiveness analysis of molecular reflex testing-based targeted therapy in non-small cell lung cancer from a German healthcare payer perspective using a decision tree model.

PubMed 1970-01-01 added 2026-07-25

Schumacher L, Kurte MS, Poos T, Thalheimer M, Griesinger F, Kron F